59.17
-1.32
(-2.18%)
As of 11:59:50 AM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
6,717,000.00
6,717,000.00
6,223,000.00
5,409,000.00
4,508,000.00
Cost of Revenue
4,769,000.00
4,769,000.00
3,785,000.00
3,299,000.00
2,660,000.00
Gross Profit
1,948,000.00
1,948,000.00
2,438,000.00
2,110,000.00
1,848,000.00
Operating Expense
1,075,000.00
1,075,000.00
1,081,000.00
1,283,000.00
916,000.00
Operating Income
873,000.00
873,000.00
1,357,000.00
827,000.00
932,000.00
Net Non Operating Interest Income Expense
-63,000.00
-63,000.00
-71,000.00
-83,000.00
-77,000.00
Pretax Income
790,000.00
790,000.00
1,448,000.00
760,000.00
803,000.00
Tax Provision
135,000.00
135,000.00
230,000.00
83,000.00
71,000.00
Net Income Common Stockholders
654,000.00
654,000.00
1,215,000.00
2,944,000.00
869,000.00
Diluted NI Available to Com Stockholders
654,000.00
654,000.00
1,215,000.00
2,944,000.00
869,000.00
Basic EPS
0.89
0.89
1.64
3.96
1.17
Diluted EPS
0.89
0.89
1.63
3.95
1.16
Basic Average Shares
736,304.69
736,304.69
742,295.94
742,558.91
744,035.08
Diluted Average Shares
736,838.25
736,838.25
743,573.36
744,901.06
747,090.49
Total Operating Income as Reported
880,000.00
880,000.00
1,541,000.00
851,000.00
901,000.00
Total Expenses
5,844,000.00
5,844,000.00
4,866,000.00
4,582,000.00
3,576,000.00
Net Income from Continuing & Discontinued Operation
654,000.00
654,000.00
1,215,000.00
2,944,000.00
869,000.00
Normalized Income
654,829.00
654,829.00
1,067,825.00
628,559.00
757,360.00
Interest Income
46,000.00
46,000.00
6,000.00
3,000.00
3,000.00
Interest Expense
93,000.00
93,000.00
63,000.00
77,000.00
71,000.00
Net Interest Income
-63,000.00
-63,000.00
-71,000.00
-83,000.00
-77,000.00
EBIT
883,000.00
883,000.00
1,511,000.00
837,000.00
874,000.00
EBITDA
1,504,000.00
1,504,000.00
2,107,000.00
1,359,000.00
1,400,000.00
Reconciled Cost of Revenue
4,769,000.00
4,769,000.00
3,785,000.00
3,299,000.00
2,660,000.00
Reconciled Depreciation
621,000.00
621,000.00
596,000.00
522,000.00
526,000.00
Net Income from Continuing Operation Net Minority Interest
654,000.00
654,000.00
1,215,000.00
674,000.00
730,000.00
Total Unusual Items Excluding Goodwill
-1,000.00
-1,000.00
175,000.00
51,000.00
-30,000.00
Total Unusual Items
-1,000.00
-1,000.00
175,000.00
51,000.00
-30,000.00
Normalized EBITDA
1,505,000.00
1,505,000.00
1,932,000.00
1,308,000.00
1,430,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-171.00
-171.00
27,825.00
5,559.00
-2,640.00
12/31/2020 - 1/20/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
NN6.F NanoRepro AG
1.4800
+5.34%
01P.F Medpace Holdings, Inc.
340.10
-0.38%
ESF0.MU Eurofins Scientific SE
50.22
+2.03%
IDHCl.XC
MVF.AX Monash IVF Group Limited
1.2050
-2.82%
DAP.DE Danaher Corporation
235.10
+1.86%
VIMIAN.ST Vimian Group AB (publ)
37.35
+0.81%
PRM.L Proteome Sciences plc
4.2500
-11.46%
GDR.L genedrive plc
2.2500
+4.65%
DAP.F Danaher Corporation
234.70
+1.80%